Engineered Microbes for Producing Anticholinergics.


Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
16 04 2021
Historique:
revised: 18 11 2020
received: 18 12 2020
pubmed: 21 11 2020
medline: 15 12 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

The tropane alkaloids (TAs) hyoscyamine and scopolamine function as acetylcholine receptor antagonists and are used clinically as parasympatholytics to treat neuromuscular disorders in humans. While TAs are synthesized in a small subset of plant families, these specialized metabolites are only accumulated in limited quantities in plant organs. The complex chemical structures of these compounds make their industrial production by chemical synthesis very challenging, Therefore, the supply of these TAs still relies on intensive farming of Duboisia shrubs in tropical countries. Many adverse factors such as climate fluctuations and pandemics can thus influence annual world production. Based on the landmark microbial production of the antimalarial semi-synthetic artemisinin, the Smolke group recently developed a yeast cell factory capable of de novo synthesizing hyoscyamine and scopolamine, thus paving the way for an alternative production of these compounds.

Identifiants

pubmed: 33215811
doi: 10.1002/cbic.202000757
doi:

Substances chimiques

Cholinergic Antagonists 0
Scopolamine DL48G20X8X
Hyoscyamine PX44XO846X

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1368-1370

Subventions

Organisme : ARD2020 and ARD CVL Biopharmaceutical program
ID : 23089

Informations de copyright

© 2020 Wiley-VCH GmbH.

Références

G. Grynkiewicz, M. Gadzikowska, Pharmacol. Rep. 2008, 60, 439-463.
A. Cravens, J. Payne, C. D. Smolke, Nat. Commun. 2019, 10, 2142.
F. M. Szczebara, C. Chandelier, C. Villeret, A. Masurel, S. Bourot, C. Duport, S. Blanchard, A. Groisillier, E. Testet, P. Costaglioli, G. Cauet, E. Degryse, D. Balbuena, J. Winter, T. Achstetter, R. Spagnoli, D. Pompon, B. Dumas, Nat. Biotechnol. 2003, 21, 143-149.
E. Pyne, L. Narcross, V. J. J. Martin, Plant Physiol. 2019, 179, 844-861.
V. Courdavault, S. E. O′Connor, A. Oudin, S. Besseau, N. Papon, Trends Cancer. 2020, 6, 444-448.
P. Srinivasan, C. D. Smolke, Nature 2020, 585, 614-619.
P. Srinivasan, C. D. Smolke, Nat. Commun. 2019, 10, 3634.
F. Qiu, J. Zeng, J. Wang, J. P. Huang, W. Zhou, C. Yang, X. Lan, M. Chen, S. X. Huang, G. Kai, Z. Liao, New Phytol. 2020, 225, 1906-1914.
T. Bontpart, V. Cheynier, A. Ageorges, N. Terrier, New Phytol. 2015, 208, 695-707.
P. S. Grewal, J. A. Samson, J. J. Baker, B. Choi, J. E. Dueber, Nat. Chem. Biol. 2020, DOI: 10.1038/s41589-020-00668-4.
T. Dugé de Bernonville, N. Papon, M. Clastre, S. E. O'Connor, V. Courdavault, Trends Pharmacol. Sci. 2020, 41, 142-146.
R. S. Nett, W. Lau, E. S. Sattely, Nature 2020, 584, 148-153.
E. A. Stander, N. Papon, V. Courdavault, ChemMedChem 2020, DOI: 10.1002/cmdc.202000633.
M. E. Pyne, K. Kevvai, P. S. Grewal, L. Narcross, B. Choi, L. Bourgeois, J. E. Dueber, V. J. J. Martin, Nat. Commun. 2020, 11, 1-10.
N. Kulagina, N. Papon, V. Courdavault, ChemBioChem 2020, DOI: 10.1002/cbic.202000579.

Auteurs

Vincent Courdavault (V)

Université de Tours, Faculté de Pharmacie, EA2106 BBV 31 avenue, Monge, 37200 Tours, France.

Julien Cassereau (J)

MitoLab, UMR CNRS 6015-INSERM 1083 MitoVasc Institute, Université d'Angers, Angers, France.

Nicolas Papon (N)

Host-Pathogen Interaction Study Group (GEIHP, EA 3142), Université d'Angers, Univ Brest, Angers, France.
Federative Structure of Research "Cellular Interactions and Therapeutic Applications" SFR 4208 ICAT, Université d'Angers, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH